期刊文献+

PET-CT在恶性淋巴瘤诊断中的价值 被引量:2

下载PDF
导出
摘要 目的:探讨PET-CT和CT检查在恶性淋巴瘤诊断中的价值。方法:回顾性分析48例恶性淋巴瘤患者的临床资料,所有患者均行PET-CT和CT扫描,以病理诊断结果作为金标准,比较CT与PET-CT对其的诊断敏感性和特异性。结果:PET-CT的诊断敏感性和特异性分别为84.21%(32/38)和90.00%(9/10),明显高于CT扫描的63.16%(24/38)和40.00%(4/10),差异有统计学意义(P<0.05)。结论:PET-CT显像技术对恶性淋巴瘤诊断效果较好,可作为制定和调整治疗方案的重要依据。
作者 张龙敏
机构地区 南阳市中心医院
出处 《中国民康医学》 2017年第17期98-99,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献6

二级参考文献68

  • 1王荣福.核医学分子功能成像和靶向治疗在淋巴瘤中临床应用进展[J].肿瘤学杂志,2009,15(9):861-865. 被引量:3
  • 2叶任高.内科学[M]5版[M].北京:人民卫生出版社,2000.961.
  • 3Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?[J]. Ann Oneol, 2006, 17( 1 ): 117-122.
  • 4Polosi E, Perma D, Douroukas A, et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multieentre study[J]. Q J Nucl Med Mol Imaging, 2011, 55(4): 469-475.
  • 5Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of Imaging Subcommittee of International Harmonization Project in lymphoma[J]. J Clin Oncol, 2007, 25 (5): 571-578.
  • 6Dupuis J, Itti E, Rahmouni A, et al. Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphorna: integrating 18ftuorodeoxyglucose positron emission tomography to the International Workshop Criteria[J]. Ann Oncol, 2009, 20 (3): 503-507.
  • 7Thomas A, Gingrich RD, Smith B J, et al. ^38F-Fluoro- deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reports [J]. Leuk Lymphoma, 2010, 51 (3): 439-446.
  • 8Mikhaeel NG. Interim Fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B-cell lymphoma: where are we know? [J]. Leuk Lymphoma, 2009, 50 (12): 1931-1936.
  • 9Chow A, Phillips M, Siew T, et al. Prognostic nomogram for diffuse large B-cell lymphoma (DLBCL) incorporating the International Prognostic Index (IPI) with interim-positron emission tomography (interim-PET) findings [J]. Inter Med J, 2013, 43(8): 932-939.
  • 10Yang DH, Min JJ, Song HC, et al. Prognostic significance of interim ^18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma [J]. Eur J Cancer, 2011, 47(9): 1312-1318.

共引文献81

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部